These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1543009)

  • 1. Cervical cytology quality assurance in Washington State.
    Taylor V; Frost F
    Acta Cytol; 1992; 36(2):246-50. PubMed ID: 1543009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 4. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
    Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance activities of the College of American Pathologists.
    Kraemer BB
    Acta Cytol; 1989; 33(4):434-8. PubMed ID: 2750430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
    Bonfiglio TA
    Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
    Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
    Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Education and training for cytopathologists. Its role in quality assurance.
    Parker JE
    Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
    MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
    Krieger P; Naryshkin S
    Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
    [No Abstract]   [Full Text] [Related]  

  • 14. In-house quality assurance program in a state cytology laboratory.
    Gardner NM
    Acta Cytol; 1989; 33(4):487-8. PubMed ID: 2750439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using urbanization profiles to assess screening performance.
    Boon ME; Kok LP
    Diagn Cytopathol; 2004 Apr; 30(4):243-6. PubMed ID: 15048958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory use of the diagnosis "reactive/reparative" in gynecologic smears: impact of CLIA '88.
    Allen KA; Zaleski MS; Cohen MB
    Mod Pathol; 1995 Apr; 8(3):266-9. PubMed ID: 7617652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controls in quality assessment in gynecologic cytology: A rational approach to workload limits for the ThinPrep imaging system.
    Renshaw AA; Elsheikh TM
    Diagn Cytopathol; 2010 Oct; 38(10):772-5. PubMed ID: 20091901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and evaluation of a national external quality control program for cervical cytology in Mexico.
    Flisser A; García-Malo F; Canepa Mde L; Doncel S; Espinoza R; Moreno R; Avila I; Pérez-Palacios G; Tapia-Conyer R; de la Fuente JR
    Salud Publica Mex; 2002; 44(5):431-6. PubMed ID: 12389486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.